TY  - GEN
AU  - Tóth,Gábor
AU  - Szöőr,Árpád
AU  - Simon,László
AU  - Yarden,Yosef
AU  - Szöllősi,János
AU  - Vereb,György
TI  - The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity
SN  - 1942-0870
PY  - 2017///1116
KW  - Animals
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antibody-Dependent Cell Cytotoxicity
KW  - drug effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Breast Neoplasms
KW  - immunology
KW  - Cell Line, Tumor
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Mice
KW  - Mice, SCID
KW  - Receptor, ErbB-2
KW  - Trastuzumab
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/19420862.2016.1204503
ER  -